Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
about
Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical RelevanceSingle-cell analysis tools for drug discovery and developmentVascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationAn LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain CancersCooperative tumour cell membrane targeted phototherapy.mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling.Anti-Epidermal Growth Factor Receptor Gene Therapy for GlioblastomaEGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment.Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.Intratumoral Heterogeneity of the Epigenome.Epidermal growth factor receptor targeting and challenges in glioblastoma.Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth.Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas.GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity.Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma.Oncogenic role of rab escort protein 1 through EGFR and STAT3 pathwayImplications of mitogen-activated protein kinase signaling in glioma.Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing.Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways.The isoprenoid derivative N6 -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway.Investigational new drugs for brain cancer.Concepts in glioma immunotherapy.Signal Peptide Peptidase, Encoded by HM13, Contributes to Tumor Progression by Affecting EGFRvIII Secretion Profiles in Glioblastoma.Single-Cell mRNA Sequencing in Cancer Research: Integrating the Genomic Fingerprint.EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment.Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.Multifunctional Transmembrane Protein Ligands for Cell-Specific Targeting of Plasma Membrane-Derived VesiclesCell adhesion heterogeneity reinforces tumour cell dissemination: novel insights from a mathematical model.Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.Association between ABO blood types and sporadic pancreatic neuroendocrine tumors in the Chinese Han population.Integrating the glioblastoma microenvironment into engineered experimental models.EGF stimulates glioblastoma metastasis by induction of matrix metalloproteinase-9 in an EGFR-dependent mechanism.Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma.
P2860
Q26750970-C736E579-9F1A-457B-88F9-702B93E1A8EAQ26775754-7D9E979E-6951-4427-8F14-E0823F5CBA64Q26781833-9E8F8354-D4DB-4A8D-B26F-CA8FE902C3A6Q33822099-B0F04BFC-C295-46C9-9877-938D4C204999Q33827119-B489699A-1364-4FB0-989E-D5B911B38153Q33884658-499E7B1B-5CDD-472D-A2AB-5DE3919AD656Q36155208-90EDD372-3B76-4640-9A9C-A3B9577CAF22Q36172699-70ADA708-FAD2-48C8-853C-26B8D9220C36Q36256815-D0F2A4F4-F55C-497F-A0BB-576E501CDCA3Q36272539-EDB33316-B131-4BC1-8BDF-A6FCA4710951Q36821054-2D71E6BE-FF5C-46F6-A8AD-F07F3D70BA65Q36854908-D253B708-6F7D-4248-8D2A-DA464EB3AF4BQ36977684-A9FA1F9C-A82C-4FD2-A7A2-EFF44B061C0FQ37095651-9BFCE935-21DB-4831-A9F3-B4E8359FD20CQ37168356-E8898D7B-AC20-4F3B-9999-489A715A476DQ37225334-BAA32689-A24C-47DA-A463-7BAC73F20AFAQ37670401-DA1B6FBC-D3A8-4DA8-B822-A13639E83488Q37694758-511C03D4-F0E9-40C6-912C-996A68DDC869Q37716459-58B01049-F3E4-47AF-BC11-23639E717EF3Q37745280-ACD74B15-1F08-4E7A-B98F-A6C37457E1CBQ38618205-F078E410-60F6-4F2D-B0A6-1BA334223311Q38733038-9BA67D85-C401-4D58-BD8D-D577DBBC18AAQ38743138-0BF93583-79F3-4C16-A057-EF80ED1406DBQ38762476-0231EF7A-3F23-495D-AEEC-250A07FAD469Q38812830-3D0730E2-12EF-49AB-8736-DF466778F070Q38820034-78247026-DAB6-43CD-A61D-65BEB6D429BFQ38832228-CFB2ADB3-3884-4660-A8EE-6C695C0A92F8Q38832510-96509E5D-3454-41C4-8BB2-A4EA7BF7BBD5Q38909071-B4B80DB3-DB18-44AD-9AFB-BAE8C94E1266Q38960961-BBED9437-F8AE-46BB-B59D-0BCC575ACA73Q39377159-70EBE4AC-393B-41B2-8B94-D4F2D6E852B6Q39383476-45797FC6-6DDC-4DFE-BBCE-50105ECCCD92Q40116157-18AF2EC9-E1DF-4320-A49E-5E83CD67D85AQ41098832-A323F04B-C31C-43D1-B245-641305A46309Q41361676-C18E17FE-5B38-44AC-8E95-00B9988B9926Q41468666-290374BD-067C-440E-8B93-A488A1415451Q41550593-EA2779EA-6929-482D-9045-88958430347DQ41609024-893A6138-2CEF-4505-8C45-0C53A02B7DF2Q42371599-E33B2904-CB72-407A-B1A4-841ECAF5CC0AQ43441906-A682ADDD-1811-42C6-B660-D7C6CFA6E7A6
P2860
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@ast
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@en
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@nl
type
label
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@ast
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@en
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@nl
prefLabel
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@ast
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@en
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@nl
P2093
P2860
P3181
P356
P1476
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
@en
P2093
Paul S Mischel
Timothy F Cloughesy
Webster K Cavenee
P2860
P2888
P304
P3181
P356
10.1038/NRC3918
P407
P577
2015-04-09T00:00:00Z
P6179
1023006309